Delivery Order SPE2DB22D1017-SPE2DB25FYSLJ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,880.31 to AmerisourceBergen Drug Corp for 30-tablet units of Vemlidy 25 mg tablets on August 28, 2025, with completion expected by August 29, 2025. This is a firm fixed price contract with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vemlidy (tenofovir alafenamide) is an antiviral medication used in the...
- The Defense Logistics Agency awarded a delivery order valued at $6,151.92 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count unit dose packages) on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used to treat chronic...
- The Defense Logistics Agency awarded a $13,509.57 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 19, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of...
- The Defense Logistics Agency awarded a delivery order valued at $12,079.93 to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Vemlidy 25 mg tablets (30-count unit). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of May 7, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication primarily used in the treatment of chronic hepatitis B, representing the type of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,656.80 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units). This contract was competitively awarded with firm fixed pricing and no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of May 14, 2025. Vemlidy is an antiviral medication used in the treatment of chronic hepatitis B,...
- The Defense Logistics Agency awarded a delivery order valued at $8,888.28 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, issued competitively to support federal medical procurement needs. The order is scheduled for completion by July 22, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vemlidy...
- The Defense Logistics Agency awarded a delivery order valued at $8,288.17 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under a larger vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication...
- The Defense Logistics Agency awarded a delivery order valued at approximately $13,969 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on September 18, 2025, with an ultimate completion date of September 19, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The performance location is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $10,560.80 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, with a contract ceiling value of $5,262.72 and an ultimate completion date of August 25, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYSLJDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,656.80 to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 30, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. Vemlidy (tenofovir alafenamide) is an antiviral medication used in hepatitis B treatment, reflecting the Defense Logistics Agency Medical Supply Chain's ongoing procurement of specialized pharmaceutical products to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply an extensive range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The company's federal procurement activity demonstrates its significant role as a critical vendor for Defense Health Agency and other government healthcare systems through competitively awarded, firm fixed-price delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 9/29/25 |